Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review

Neuromuscul Disord. 2022 Feb;32(2):99-115. doi: 10.1016/j.nmd.2021.09.014. Epub 2021 Oct 8.

Abstract

Measurement of muscle strength is fundamental for the management of patients with myotonic dystrophy type 1 (DM1). Nevertheless, guidance on this topic is somewhat limited due to heterogeneous outcome measures used. This systematic literature review aimed to summarize the most frequent outcome measures to assess muscle strength in patients with DM1. We searched on Pubmed, Web of Science and Embase databases. Observational studies using measures of muscle strength assessment in adult patients with DM1 were included. From a total of 80 included studies, 24 measured cardiac, 45 skeletal and 23 respiratory muscle strength. The most common method and outcome measures used to assess cardiac muscle strength were echocardiography and ejection fraction, for skeletal muscle strength were quantitative muscle test, manual muscle test and maximum isometric torque and medical research council and for respiratory muscle strength were manometry and maximal inspiratory and expiratory pressure. We successfully gathered the more consensual methods and measures to evaluate muscle strength in future clinical studies, particularly to test muscle strength response to treatments in patients with DM1. Future consensus on a set of measures to evaluate muscle strength (core outcome set), is important for these patients.

Keywords: Cardiac muscle strength; Myotonic dystrophy type 1; Respiratory muscle strength; Skeletal muscle strength.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Humans
  • Muscle Strength / physiology
  • Muscle, Skeletal / diagnostic imaging
  • Muscle, Skeletal / physiology
  • Myotonic Dystrophy* / therapy
  • Outcome Assessment, Health Care
  • Torque